The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Insulin resistance and hyperglycaemia in cardiovascular disease development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Self-citationOxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Self-citationInoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N., & Baron, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,223
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Self-citationDiabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask-Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 846
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Self-citationMortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724
Diabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 695
Krolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654
Adipocyte Turnover: Relevance to Human Adipose Tissue Morphology
Arner, E., Westermark, P. O., Spalding, K. L., Britton, T., Rydén, M., Frisén, J., Bernard, S., & Arner, P. (2010) · Diabetes · doi:10.2337/db09-0942 · Cited by 645
The Origins and Drivers of Insulin Resistance
Johnson, A. M. F., & Olefsky, J. M. (2013) · Cell · doi:10.1016/j.cell.2013.01.041 · Cited by 643
Diabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 545
Schramm, T. K., Gislason, G. H., Køber, L., Rasmussen, S., Rasmussen, J. N., Abildstrøm, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.720847 · Cited by 538
Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
The 30-Year Natural History of Type 1 Diabetes Complications
Pambianco, G., Costacou, T., Ellis, D., Becker, D. J., Klein, R., & Orchard, T. J. (2006) · Diabetes · doi:10.2337/db05-1423 · Cited by 493
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492
Affner, S. T. M. H., Ehto, S. E. L., Önnemaa, T. A. R., Yörälä, K. A. P., & Aakso, M. A. L. (1998) · Cited by 480
Type 2 Diabetes as a “Coronary Heart Disease Equivalent”
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2901 · Cited by 452
Self-citationInsulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1982 · Cited by 439
Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk
Juutilainen, A., Kortelainen, S., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2898 · Cited by 431
Self-citationMetabolic Syndrome in Type 1 Diabetes
Thorn, L. M., Forsblom, C., Fagerudd, J., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Wadén, J., Rönnback, M., Rosengård-Bärlund, M., Björkesten, C.-G. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2019 · Cited by 423
Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052036 · Cited by 403
Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes
Tushuizen, M. E., Bunck, M. C., Pouwels, P. J., Bontemps, S., van Waesberghe, J. H. T., Schindhelm, R. K., Mari, A., Heine, R. J., & Diamant, M. (2007) · Diabetes Care · doi:10.2337/dc07-0326 · Cited by 400
Gujral, U. P., Pradeepa, R., Weber, M. B., Narayan, K. M. V., & Mohan, V. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06838.x · Cited by 398
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & Idris, I. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälä, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 375
Self-citationMyoishi, M., Hao, H., Minamino, T., Watanabe, K., Nishihira, K., Hatakeyama, K., Asada, Y., Okada, K.-I., Ishibashi-Ueda, H., Gabbiani, G., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.682054 · Cited by 370
Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men1
Chandalia, M., Abate, N., Garg, A., Stray-Gundersen, J., & Grundy, S. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5817 · Cited by 348
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db08-1607 · Cited by 348
Self-citationDu, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Livingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S., Leese, G. P., McKnight, J., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 345
Obstfeld, A. E., Sugaru, E., Thearle, M., Francisco, A.-M., Gayet, C., Ginsberg, H. N., Ables, E. V., & Ferrante, A. W. (2010) · Diabetes · doi:10.2337/db09-1403 · Cited by 314
Type 1 diabetes and coronary artery disease
Orchard, T. J., Costacou, T., Kretowski, A., & Nesto, R. W. (2006) · Diabetes Care · doi:10.2337/dc06-1161 · Cited by 305
Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension
Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., & Mary, D. A. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000103123.66264.fe · Cited by 305
Natural Course of Insulin Resistance in Type I Diabetes
Yki-Järvinen, H., & Koivisto, V. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150404 · Cited by 304
Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms
Laakso, M. (2010) · Diabetes Care · doi:10.2337/dc09-0749 · Cited by 300
Self-citationTestosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292
Carmienke, S., Freitag, M. H., Pischon, T., Schlattmann, P., Fankhaenel, T., Goebel, H., & Gensichen, J. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.61 · Cited by 288
Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., & Sattar, N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2 · Cited by 281
Han, S., Liang, C.-P., DeVries-Seimon, T., Ranalletta, M., Welch, C. L., Collins-Fletcher, K., Accili, D., Tabas, I., & Tall, A. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.008 · Cited by 273
Purnell, J. Q., Zinman, B., & Brunzell, J. D. (2013) · Circulation · doi:10.1161/circulationaha.111.077487 · Cited by 267
Cleary, P. A., Orchard, T. J., Genuth, S., Wong, N. D., Detrano, R., Backlund, J.-Y. C., Zinman, B., Jacobson, A., Sun, W., Lachin, J. M., et al. (2006) · Diabetes · doi:10.2337/db06-0653 · Cited by 264
Stegenga, M. E., van der Crabben, S. N., Levi, M., de Vos, A. F., Tanck, M. W., Sauerwein, H. P., & van der Poll, T. (2006) · Diabetes · doi:10.2337/db05-1543 · Cited by 251
Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe
Soedamah-Muthu, S. S., Chaturvedi, N., Toeller, M., Ferriss, B., Reboldi, P., Michel, G., Manes, C., Fuller, J. H., & the EURODIAB Prospective Complications Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.2.530 · Cited by 251
Dabelea, D., Kinney, G., Snell-Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S., Hamman, R. F., & Rewers, M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2833 · Cited by 250
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N., & Petrie, J. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2904-2 · Cited by 238
Ectopic lipid storage and insulin resistance: a harmful relationship
Borén, J., Taskinen, M. ‐., Olofsson, S. ‐., & Levin, M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12071 · Cited by 234
Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011) · Diabetes · doi:10.2337/db10-0328 · Cited by 230
Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention
Laakso, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00789.x · Cited by 230
Self-citationVascular system: role of nitric oxide in cardiovascular diseases
Bian, K., Doursout, M., & Murad, F. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.06632.x · Cited by 229
Insulin resistance and coronary artery disease
Bressler, P., Bailey, S. R., Matsuda, M., & DeFronzo, R. A. (1996) · Diabetologia · doi:10.1007/s001250050581 · Cited by 226
Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2007) · Diabetes Care · doi:10.2337/dc06-1747 · Cited by 209
Self-citationHayashi, T., Boyko, E. J., McNeely, M. J., Leonetti, D. L., Kahn, S. E., & Fujimoto, W. Y. (2008) · Diabetes · doi:10.2337/db07-1378 · Cited by 207
Asymptomatic atherosclerosis and insulin resistance.
Laakso, M., Sarlund, H., Salonen, R., Suhonen, M., Pyörälä, K., Salonen, J. T., & Karhapää, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1068 · Cited by 206
Self-citationThe Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis
Fall, T., Hägg, S., Mägi, R., Ploner, A., Fischer, K., Horikoshi, M., Sarin, A.-P., Thorleifsson, G., Ladenvall, C., Kals, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001474 · Cited by 203
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2008) · Diabetes Care · doi:10.2337/dc07-2124 · Cited by 194
Self-citationSoinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Self-citationDunn, E. J., Philippou, H., Ariëns, R. A. S., & Grant, P. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0197-4 · Cited by 177
Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus
Taskinen, M.-R. (1992) · Diabetes · doi:10.2337/diab.41.2.s12 · Cited by 173
Eddy, D. M., Schlessinger, L., Kahn, R., Peskin, B., & SCHIEBINGER, R. J. (2008) · Diabetes Care · doi:10.2337/dc08-0854 · Cited by 169
Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Hanssen, K. F., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0687-z · Cited by 165
Self-citationde Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.
Chiu, K. C., Cohan, P., Lee, N. P., & Chuang, L. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1353 · Cited by 154
Insulin resistance and coronary heart disease
Laakso, M. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199608000-00008 · Cited by 152
Self-citationDiabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice
Parathath, S., Grauer, L., Huang, L., Sanson, M., Distel, E., Goldberg, I. J., & Fisher, E. A. A. (2011) · Diabetes · doi:10.2337/db10-0778 · Cited by 141
Type 2 diabetes mellitus—an autoimmune disease?
Velloso, L. A., Eizirik, D. L., & Cnop, M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.131 · Cited by 133
Asymptomatic atherosclerosis and insulin resistance.
MLaakso, HSarlund, RSalonen, MSuhonen, KPyörälä, TSalonen, J., & PKarhapää (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 133
Baumgartl, J., Baudler, S., Scherner, M. P., Babaev, V. R., Makowski, L., Suttles, J., MCDUFFIE, M. J., Fazio, S., Kahn, C. R., Hotamışlıgil, G. S., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.010 · Cited by 127
Type 1 diabetes, hyperglycaemia, and the heart
Retnakaran, R. R., & Zinman, B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60767-9 · Cited by 127
Thorn, L. M., Forsblom, C. M., Wadén, J., Saraheimo, M., Tolonen, N., Hietala, K., Groop, P., & for the Finnish Diabetic Nephropathy (FinnDiane) Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2022 · Cited by 122
Early Signs of Atherosclerosis in Diabetic Children on Intensive Insulin Treatment
Margeirsdottir, H. D., Stensæth, K. H., Larsen, J. R., Brunborg, C., & Dahl‐Jørgensen, K. (2010) · Diabetes Care · doi:10.2337/dc10-0505 · Cited by 119
Heart in Diabetes: A Microvascular Disease
Laakso, M. (2011) · Diabetes Care · doi:10.2337/dc11-s209 · Cited by 112
Self-citationLopes-Virella, M. F., Hunt, K. J., Baker, N. L., Lachin, J. M., Nathan, D. M., & Virella, G. (2010) · Diabetes · doi:10.2337/db10-0915 · Cited by 108
Targher, G., Bertolini, L., Zenari, L., Lippi, G., Pichiri, I., Zoppini, G., Muggeo, M., & Arcaro, G. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02327.x · Cited by 101
Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M. A., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., & and the DCCT/EDIC Cohort Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0659 · Cited by 101
Cause-specific mortality in diabetes: recent changes in trend mortality
Khalil, C. A., Roussel, R., Mohammedi, K., Danchin, N., & Marre, M. (2012) · European Journal of Preventive Cardiology · doi:10.1177/1741826711409324 · Cited by 98
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
Porter, K. E., & Riches‐Suman, K. (2013) · Clinical Science · doi:10.1042/cs20120413 · Cited by 87
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction
Benn, M., Tybjærg‐Hansen, A., McCarthy, M. I., Jensen, G. B., Grande, P., & Nordestgaard, B. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.043 · Cited by 85
Cardiovascular Disease Risk in Young People with Type 1 Diabetes
Snell‐Bergeon, J. K., & Nadeau, K. J. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9363-x · Cited by 84
Collado‐Mesa, F., Colhoun, H. M., Stevens, L. K., Boavida, J. M., Ferriss, J. B., Karamanos, B. G., Kempler, P., Michel, G., Roglić, G., Fuller, J., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00007.x · Cited by 78
Specht, B. J., Wadwa, R. P., Snell‐Bergeon, J. K., Nadeau, K. J., Bishop, F. K., & Maahs, D. M. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.07.036 · Cited by 77
Global burden of disease—where does diabetes mellitus fit in?
Alberti, K. G. M. M., & Zimmet, P. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.54 · Cited by 71
Lindsey, J. B., House, J. A., Kennedy, K. F., & Marso, S. P. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.876672 · Cited by 69
Djaberi, R., Schuijf, J. D., Boersma, E. H., Kroft, L. J. M., Pereira, A. M., Romijn, J. A., Scholte, A. J. H. A., Jukema, J. W., & Bax, J. J. (2009) · Diabetes Care · doi:10.2337/dc09-0320 · Cited by 69
Longitudinal Lipid Screening and Use of Lipid-Lowering Medications in Pediatric Type 1 Diabetes
Maahs, D. M., Wadwa, R. P., McFann, K., Nadeau, K. J., Williams, M. R., Eckel, R. H., & KLINGENSMITH, G. J. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.10.054 · Cited by 68
Plasminogen Activator Inhibitor-1 Activity in Type 2 Diabetes
Brazionis, L., Rowley, K., Jenkins, A. J., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160168 · Cited by 55
Update on Type 2 Diabetes as a Cardiovascular Disease Risk Equivalent
Kuusisto, J., & Laakso, M. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0331-5 · Cited by 44
Self-citationMayer‐Davis, E. J., Ma, B., Lawson, A. B., D'Agostino, R. B., Liese, A. D., Bell, R. A., Dabelea, D., Dolan, L. M., Pettitt, D. J., Rodríguez, B. L., et al. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0046 · Cited by 43
Sex Differences in Cardiovascular Disease Risk in Adolescents With Type 1 Diabetes
Krishnan, S., Fields, D. A., Copeland, K. C., Blackett, P. R., Anderson, M. P., & Gardner, A. W. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.05.003 · Cited by 23
Mays, D. M., Streisand, R. M., Walker, L. R., Prokhorov, A. V., & Tercyak, K. P. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.005 · Cited by 22
Cited by
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Diabetes primes neutrophils to undergo NETosis, which impairs wound healing
Wong, S. L., Demers, M., Martinod, K., Gallant, M., Wang, Y., Goldfine, A. B., Kahn, C. R., & Wagner, D. D. (2015) · Nature Medicine · doi:10.1038/nm.3887 · Cited by 1,264
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Metadata
- Authors
- Laakso, M., & Kuusisto, J.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-03-25
- Volume
- 10
- Issue
- 5
- Pages
- 293-302
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2053091858
- Cited by
- 858
- References
- 124
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.